Yasunari Miyazaki Selected Research

Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)

6/2022	Understanding the process of people with hypersensitivity pneumonitis implementing continuous antigen avoidance and their affecting situations: A grounded theory study.
5/2022	Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis.
1/2022	Successful diagnosis of humidifier lung by individual provocation test to a responsible environment, a case report.
1/2022	Alternative Gene Expression by TOLLIP Variant Is Associated With Lung Function in Chronic Hypersensitivity Pneumonitis.
7/2021	Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis.
4/2021	Screening and diagnosis of acute and chronic bird-related hypersensitivity pneumonitis by serum IgG and IgA antibodies to bird antigens with ImmunoCAP®.
12/2020	Disruption in the balance between apolipoprotein A-I and mast cell chymase in chronic hypersensitivity pneumonitis.
11/2020	Changes in serum KL-6 levels during short-term strict antigen avoidance are associated with the prognosis of patients with fibrotic hypersensitivity pneumonitis caused by avian antigens.
1/2020	Hypersensitivity pneumonitis.
7/2019	Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasunari Miyazaki Research Topics

Disease

38	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 06/2022 - 05/2003
20	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2022 - 06/2002
9	Pneumonia (Pneumonitis) 01/2021 - 10/2003
8	Lung Diseases (Lung Disease) 01/2022 - 03/2012
7	COVID-19 09/2022 - 01/2020
7	Idiopathic Pulmonary Fibrosis 12/2020 - 07/2003
7	Infections 01/2019 - 01/2008
6	Fibrosis (Cirrhosis) 07/2021 - 09/2007
5	Disease Progression 05/2022 - 07/2003
5	Bronchiectasis 07/2021 - 09/2007
5	Inflammation (Inflammations) 01/2021 - 10/2003
5	Asthma (Bronchial Asthma) 03/2019 - 10/2003
4	Neoplasms (Cancer) 11/2022 - 12/2011
4	Lung Neoplasms (Lung Cancer) 11/2022 - 02/2020
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2013
4	Sarcoidosis (Schaumann Disease) 01/2018 - 09/2012
4	Vascular Diseases (Vascular Disease) 12/2015 - 03/2007
3	Respiratory Insufficiency (Respiratory Failure) 06/2022 - 11/2019
3	Hemorrhage 01/2021 - 07/2011
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2020 - 12/2010
2	Thromboembolism 01/2022 - 07/2011
2	Emphysema 04/2021 - 12/2018
2	Granuloma 01/2021 - 01/2015
2	Thrombosis (Thrombus) 01/2021 - 07/2011
2	Pneumothorax 01/2020 - 10/2010
2	Dyspnea (Shortness of Breath) 01/2018 - 07/2011
2	Dermatomyositis (Dermatopolymyositis) 03/2012 - 06/2002
1	Brain Death (Brain Dead) 06/2022
1	Hypertension (High Blood Pressure) 06/2021
1	Critical Illness (Critically Ill) 01/2021
1	Atrial Fibrillation 01/2021
1	Hematoma 01/2021
1	Pneumoconiosis 02/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Insulinoma 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Perinatal Death 11/2019
1	Cough 10/2019
1	Idiopathic Interstitial Pneumonias 07/2019

Drug/Important Bio-Agent (IBA)

30	AntigensIBA 06/2022 - 02/2007
8	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 07/2003
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2010
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2015
6	AntibodiesIBA 04/2021 - 10/2003
5	Immunoglobulin G (IgG)IBA 04/2021 - 10/2003
5	CytokinesIBA 07/2019 - 05/2003
5	CollagenIBA 12/2015 - 03/2007
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 05/2022 - 01/2015
3	fibrin fragment D (D-dimer)IBA 06/2021 - 07/2011
3	Immunoglobulin A (IgA)IBA 04/2021 - 10/2011
3	Interleukin-17 (Interleukin 17)IBA 01/2021 - 09/2012
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
3	ChemokinesIBA 07/2019 - 03/2012
3	SteroidsIBA 01/2019 - 06/2002
3	OvalbuminIBA 01/2018 - 10/2003
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2015 - 06/2002
3	Messenger RNA (mRNA)IBA 09/2012 - 05/2003
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2013
2	favipiravirIBA 12/2021 - 01/2021
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2020 - 01/2018
2	IsocyanatesIBA 09/2013 - 05/2003
2	ProteomeIBA 03/2012 - 12/2010
1	A-factor (Streptomyces)IBA 09/2022
1	RNA (Ribonucleic Acid)IBA 09/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Methylprednisolone FDA LinkGeneric 12/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021
1	Immunoglobulins (Immunoglobulin)IBA 07/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2021
1	AnticoagulantsIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	ART123IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Chymases (Chymase)IBA 12/2020
1	TitaniumIBA 02/2020
1	titanium dioxide (Titania)FDA Link 02/2020
1	CosmeticsIBA 02/2020
1	MetalsIBA 02/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	SynaptophysinIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	NivolumabIBA 01/2020
1	Chromogranin AIBA 01/2020
1	DisulfidesIBA 11/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2019
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2019

Therapy/Procedure

12	Therapeutics 11/2022 - 07/2003
5	Traction 07/2021 - 09/2007
2	Immunotherapy 11/2022 - 01/2022
2	Lung Transplantation 06/2022 - 04/2019
2	Drug Therapy (Chemotherapy) 02/2020 - 01/2020
1	Extracorporeal Membrane Oxygenation 06/2022
1	Humidifiers 01/2022
1	Noninvasive Ventilation 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2020